Lipocine (NASDAQ: LPCN) commenced an underwritten public offering of its common stock. In addition, Lipocine expects to grant the underwriters ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE